3.97
-0.51(-11.38%)
Currency In USD
| Previous Close | 4.48 |
| Open | 4.32 |
| Day High | 4.75 |
| Day Low | 3.87 |
| 52-Week High | 152 |
| 52-Week Low | 3.87 |
| Volume | 130,956 |
| Average Volume | 524,949 |
| Market Cap | 6.4M |
| PE | -0.2 |
| EPS | -19.74 |
| Moving Average 50 Days | 10.81 |
| Moving Average 200 Days | 32.31 |
| Change | -0.51 |
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
GlobeNewswire Inc.
Nov 25, 2024 9:00 PM GMT
THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced the closing of its previo
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering
GlobeNewswire Inc.
Nov 22, 2024 2:15 PM GMT
THE WOODLANDS, TX, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced the pricing of an underwr
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update
GlobeNewswire Inc.
Nov 11, 2024 1:00 PM GMT
Ongoing proof-of-concept (PoC) clinical trial in pain associated with pancreatic cancer; Preliminary results demonstrate 100% of the lead-in patient responder group went to zero opioid use at 4-6 weeks post-procedure Company’s first-in-class technol